This week, Sanofi announced intentions to re-launch Zantac under the name Zantac 360, which will use the active ingredient from Pepcid instead of ranitidine, which has been linked to increased…
A Zantac lawsuit filed by a California woman indicates decades of using the now-recalled heartburn drug led to the development of breast cancer.
A new study links Zantac use, particularly long-term use, with an increased risk of bladder cancer.
GlaxoSmithKline has sold a plant in India once used to make the recalled heartburn drug Zantac for only a fraction of its initial cost.
Plaintiffs have filed two amended class action lawsuits in Zantac cancer litigation, seeking for manufacturers to pay for economic losses and medical monitoring for those who took the recalled heartburn…
Two new studies appear to strengthen the science indicating Zantac's active ingredient, ranitidine, converts to the cancer-causing chemical NDMA duriing digestive processes.
Plaintiffs say they plan to show how numerous types of cancer are linked to the side effects of Zantac, which has been recalled due to high levels of the toxic…
Zantac lawsuits continue to be filed as more former users learn the heartburn drug they used for years may have caused them to develop cancer.
Plaintiffs are defending their right to file Zantac lawsuits in the face of an attempt by generic manufacturers and repackagers to have cases not involving actual claims of cancer dismissed.
A year after the first warnings of Zantac NDMA contamination, the drug has been removed from store shelves, and cancer claims continue to be filed.
